Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis

Respiratory Medicine

Volumn 107, Issue 7, 2013, Pages 1079-1086

  Hesselstrand, Roger ^a   Wildt, Marie ^a   Bozovic, Gracijela ^a   Andersson Sjöland, Annika ^b   Andréasson, Kristofer ^a   Scheja, Agneta ^a   Westergren Thorsson, Gunilla ^b   Bjermer, Leif ^a   Wuttge, Dirk M ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Biomarker; Bronchoalveolar; Interstitial lung disease; lavage; Lung fibrosis; Scleroderma; Systemic sclerosis

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CALGRANULIN A; CALGRANULIN B; CYCLOPHOSPHAMIDE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; PREDNISOLONE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL; NEUTROPHIL COUNT; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TOTAL LUNG CAPACITY; VITAL CAPACITY;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CALGRANULIN A; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CASE-CONTROL STUDIES; CHEMOKINE CXCL5; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCIN-1; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878923690     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.03.015     Document Type: Article

References (37)

1. E.C. LeRoy, C. Black, R. Fleischmajer, S. Jablonska, T. Krieg, and T.A. Medsger Jr. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 1988 202 205 (Pubitemid 18073738)
2. R. Hesselstrand, A. Scheja, and A. Åkesson Mortality and causes of death in a Swedish series of systemic sclerosis patients Ann Rheum Dis 57 1998 682 686 (Pubitemid 28558973)
3. V.D. Steen, and T.A. Medsger Jr. Changes of causes of death in systemic sclerosis, 1972-2002 Ann Rheum Dis 66 2007 940 944 (Pubitemid 46999798)
4. N.S. Goh, S.R. Desai, S. Veeraraghavan, D.M. Hansell, S.J. Copley, and T.M. Maher Interstitial lung disease in systemic sclerosis: a simple staging system Am J Respir Crit Care Med 177 2008 1248 1254 (Pubitemid 351860934)
5. N.S. Goh, S. Veeraraghavan, S.R. Desai, D. Cramer, D.M. Hansell, and C.P. Denton Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression Arthritis Rheum 56 2007 2005 2012 (Pubitemid 47110399)
6. C. Strange, M.B. Bolster, M.D. Roth, R.M. Silver, A. Theodore, and J. Goldin Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease Am J Respir Crit Care Med 177 2008 91 98
7. M. De Santis, S.L. Bosello, G. Peluso, M. Pinelli, S. Aliverini, and G. Zizzo Bronchoalveolar lavage fluid and progression of scleroderma interstitial disease Clin Respir J 6 2012 9 17
8. K. Schmidt, L. Martinez-Gamboa, S. Meier, C. Witt, C. Meisel, and L.G. Hanitsch Bronchoalveolar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients Arthritis Res Ther 11 4 2009 R111
9. D. Bouros, A.U. Wells, A.G. Nicholson, T.V. Colby, V. Polychronopoulos, and P. Pantelidis Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome Am J Respir Crit Care Med 165 2002 1581 1586 (Pubitemid 34693935)
10. V. Falanga, and T.A. Medsger Jr. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis J Am Acad Dermatol 17 1987 648 656 (Pubitemid 17147810)
11. K.A. Boomars, S.S. Wagenaar, P.G. Mulder, H. van Velzen-Blad, and J.M. van den Bosch Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis Thorax 50 1995 1087 1092
12. K. Fujimoto, K. Kubo, S. Yamaguchi, T. Honda, and Y. Matsuzawa Eosinophil activation in patients with pulmonary fibrosis Chest 108 1995 48 54
13. S.I. Cha, C.S. Chang, E.K. Kim, J.W. Lee, M.A. Mattthay, and J.A. Golden Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis Histopathology 61 2012 98 106
14. T. Persson, N. Monsef, P. Andersson, A. Bjartell, J. Malm, and J. Calafat Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils Clin Exp Allergy 33 2003 531 537 (Pubitemid 36520920)
15. Y. Qiu, J. Zhu, V. Bandi, K.K. Guntupalli, and P.K. Jeffery Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma Thorax 62 2007 475 482 (Pubitemid 46910124)
16. K.M. Antoniou, A. Tzouvelekis, M.G. Alexandrakis, K. Sfiridaki, I. Tsiligianni, and G. Rachiotis Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis Chest 130 2006 982 988 (Pubitemid 44583725)
17. B. Wolff, A.R. Burns, J. Middleton, and A. Rot Endothelial cell "memory" of inflammatory stimulation: human venular endothelial cells store Interleukin 8 in Weibel-Palade bodies J Exp Med 188 1998 1757 1762 (Pubitemid 28516120)
18. S.B. Early, K. Hise, J.K. Han, L. Borish, and J.W. Steinke Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts Laryngoscope 117 2007 511 515 (Pubitemid 46407764)
19. A.M. Southcott, K.P. Jones, D. Li, S. Majumdar, A.D. Cambrey, and P. Pantelidis Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis Am J Respir Crit Care Med 151 1995 1604 1612
20. M.B. Bolster, A. Ludwicka, S.E. Sutherland, C. Strange, and R.M. Silver Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis Arthritis Rheum 40 1997 743 751
21. B. Crestini, N. Seta, E. Palazzo, C. Rolland, P. Venembre, and M. Dehoux Interleukin-8 and neutrophils in systemic sclerosis with lung involvement Am J Crit Care Med 150 1994 1363 1367 (Pubitemid 24356653)
22. K. Andréasson, A. Schaje, T. Saxne, B. Ohlsson, and R. Hesselstrand Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis J Intern Med 270 2011 50 57
23. N.M. Korthagen, M.M. Nagtegaal, C.H. van Moorsel, K.M. Kazemier, J.M. van den Bosch, and J.C. Grutters MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases Clin Exp Immunol 161 2010 342 347
24. E. Bargagli, A. Prasse, C. Olivieri, J. Muller-Quernheim, and P. Rottoli Macrophage-derived biomarkers of idiopathic pulmonary fibrosis Pulm Med 2011 2011 717130
25. A. Hara, N. Sakamoto, Y. Ishimatsu, T. Kakugawa, S. Nakashima, and S. Hara S100A9 in BLAF is a candidate biomarker of idiopathic pulmonary fibrosis Respir Med 106 2012 571 580
26. E. Hedbom, P. Antonsson, A. Hjerpe, D. Aeschlimann, M. Paulsson, and E. Rosa-Pimentel Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage J Biol Chem 267 1992 6132 6136
27. R. Hesselstrand, A. Kassner, D. Heinegård, and T. Saxne COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker Ann Rheum Dis 67 2008 1242 1248
28. R. Hesselstrand, K. Andréasson, D.M. Wuttge, G. Bozovic, A. Scheja, and T. Saxne Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease Rheumatology (Oxford) 51 2012 915 920
29. K. Yanaba, M. Hasegawa, K. Takehara, and S. Sato Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis J Rheumatol 31 2004 1112 1120 (Pubitemid 38715886)
30. A.T. Masi, T.A. Medsger Jr., R.D. Altman, W.A. D'Angelo, J.F. Fries, and E.C. LeRoy Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthritis Rheum 23 1980 581 590
31. P. Clements, P. Lachenbruch, J. Seibold, B. Zee, V.D. Steen, and P. Brennan Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis J Rheumatol 22 1995 1281 1285
32. M. Remy-Jardin, F. Giraud, J. Remy, M.C. Copin, B. Gosselin, and A. Duhamel Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation Radiology 189 1993 693 698 (Pubitemid 23354479)
33. D.M. Wuttge, G. Bozovic, R. Hesselstrand, D. Aronsson, L. Bjermer, and A. Scheja Increased alveolar nitric oxide in early systemic sclerosis Clin Exp Rheumatol 28 5 Suppl. 62 2010 S5 S9
34. R.M. Silver, K.S. Miller, M.B. Kinsella, E.A. Smith, and S.I. Schabel Evaluation and management of scleroderma lung disease using bronchoalveolar lavage Am J Med 88 1990 470 476 (Pubitemid 20168722)
35. D.P. Tashkin, R. Elashoff, P.J. Clements, J. Goldin, M.D. Roth, and D.E. Furst Cyclophosphamide versus placebo in scleroderma lung disease N Engl J Med 354 2006 2655 2666
36. D.P. Tashkin, R. Elashoff, P.J. Clements, M.D. Roth, D.E. Furst, and R.M. Silver Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease Am J Respir Crit Care Med 176 2007 1026 1034 (Pubitemid 350127847)
37. B. Gudbjörnsson, R. Hällgren, O. Nettelbladt, R. Gustafsson, A. Mattsson, and E. af Geijerstam TH. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome Ann Rheum Dis 53 1994 574 579 (Pubitemid 24302313)